Literature DB >> 1768378

HIV-1 Nef protein exhibits structural and functional similarity to scorpion peptides interacting with K+ channels.

T Werner1, S Ferroni, T Saermark, R Brack-Werner, R B Banati, R Mager, L Steinaa, G W Kreutzberg, V Erfle.   

Abstract

The persistent infection of human glial cells with HIV-1 is characterized by prominent expression of the Nef protein. In order to evaluate the possible role of Nef in the development of HIV-1-associated neurological disorders, we compared Nef with known neuroactive proteins. We found that HIV Nef shares sequence and structural features with scorpion peptides known to interact with K+ channels. Sequence similarity encompasses two distinct regions of scorpion peptides. Based on crystallography data, both regions in scorpion peptides cooperate in forming a common domain stabilized by ion pairs between charged amino-acid residues. Recombinant Nef protein, as well as a synthetic part of a scorpion channel active peptide (M10), reversibly increased the total K+ current of chick dorsal root ganglions in patch-clamp experiments without killing the cells. These results indicate that a region conserved in HIV Nef and scorpion peptides concurs in both structure and electrophysiological activity and suggest that Nef, like scorpion peptides, may affect neuronal cell function.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1768378     DOI: 10.1097/00002030-199111000-00003

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  25 in total

1.  Molecular Mechanisms of Neurodegenerative Diseases Induced by Human Retroviruses: A Review.

Authors:  Bryan P Irish; Zafar K Khan; Pooja Jain; Michael R Nonnemacher; Vanessa Pirrone; Saifur Rahman; Nirmala Rajagopalan; Joyce B Suchitra; Kate Mostoller; Brian Wigdahl
Journal:  Am J Infect Dis       Date:  2009-07-01

Review 2.  Voltage-gated potassium channels in human immunodeficiency virus type-1 (HIV-1)-associated neurocognitive disorders.

Authors:  James Keblesh; Dehui Hu; Huangui Xiong
Journal:  J Neuroimmune Pharmacol       Date:  2008-05-06       Impact factor: 4.147

3.  Expression of the HIV-1 Nef protein in the baculovirus system: investigation of anti-Nef antibodies response in human sera and subcellular localization of Nef.

Authors:  N Kienzle; M Enders; M Buck; H Siakkou; S Jahn; G Petzold; K E Schneweis; M Bachmann; W E Müller; N Müller-Lantzsch
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

4.  Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo.

Authors:  D C Shugars; M S Smith; D H Glueck; P V Nantermet; F Seillier-Moiseiwitsch; R Swanstrom
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

5.  Molecular mimicry between the human immunodeficiency virus type 1 gp120 V3 loop and human brain proteins.

Authors:  J R Trujillo; M F McLane; T H Lee; M Essex
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

Review 6.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

Review 7.  HIV-related neuronal injury. Potential therapeutic intervention with calcium channel antagonists and NMDA antagonists.

Authors:  S A Lipton
Journal:  Mol Neurobiol       Date:  1994 Apr-Jun       Impact factor: 5.590

8.  Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic.

Authors:  A Nath; K Psooy; C Martin; B Knudsen; D S Magnuson; N Haughey; J D Geiger
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

Review 9.  HIV-1 Nef in macrophage-mediated disease pathogenesis.

Authors:  Susanna L Lamers; Gary B Fogel; Elyse J Singer; Marco Salemi; David J Nolan; Leanne C Huysentruyt; Michael S McGrath
Journal:  Int Rev Immunol       Date:  2012-12       Impact factor: 5.311

10.  Mechanisms and structural determinants of HIV-1 coat protein, gp41-induced neurotoxicity.

Authors:  D C Adamson; K L Kopnisky; T M Dawson; V L Dawson
Journal:  J Neurosci       Date:  1999-01-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.